Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis
Abstract This study was proposed to compare the relative efficacy and tolerability of the second and third generation AEDs for refractory epilepsy. The 50% responder rate (RR) was selected as the efficacy outcome whereas the incidence of dizziness and somnolence were considered to evaluate the toler...
Guardado en:
Autores principales: | Chuanjun Zhuo, Ronghuan Jiang, Gongying Li, Mingjing Shao, Ce Chen, Guangdong Chen, Hongjun Tian, Jie Li, Rong Xue, Deguo Jiang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/47bff92694b1487fb93ee5230ff781d4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Efficacy and Safety of Lacosamide as an Adjunctive Treatment in Adults With Refractory Epilepsy
por: Liyan Hou, et al.
Publicado: (2021) -
Associated Factors in Response to Treatment in Children with Refractory Epilepsy
por: MM Nasehi, et al.
Publicado: (2010) -
Ictal heart rate changes and the effects of vagus nerve stimulation for patients with refractory epilepsy
por: Chen W, et al.
Publicado: (2017) -
A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy
por: Chen D, et al.
Publicado: (2019) -
Treating Lennox–Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide
por: Jessica Gresham, et al.
Publicado: (2010)